Carrier in Bioinformatics

Harness the power of AI-driven genomic insights to transition from reactive treatments to proactive precision medicine. Master the clinical implementation of pharmacogenetics to optimize drug efficacy and eliminate adverse drug reactions (ADRs).

Webinar Recorded All Levels Dr. Omics
Language English
Level All Levels
Updated Feb 2026
Carrier in Bioinformatics

Course Description

In the 2026 healthcare landscape, Pharmacogenomics (PGx) has evolved from a niche research interest into a cornerstone of Precision Medicine. This course provides an end-to-end framework for translating molecular genetic data into actionable clinical prescriptions. You will explore how Generative AI and Machine Learning (ML) algorithms are revolutionizing the interpretation of complex SNPs and structural variants to predict patient-specific drug responses. The curriculum covers the entire "Bench to Bedside" pipeline, including high-throughput Next-Generation Sequencing (NGS), variant annotation, and the integration of Clinical Decision Support (CDS) tools into Electronic Health Records (EHR). Participants will gain a deep understanding of CYP450 polymorphisms and their impact on drug metabolism across diverse therapeutic areas like oncology, cardiology, and psychiatry. By leveraging Big Data analytics and Biomedical Informatics, you will learn to navigate CPIC guidelines and FDA regulatory requirements. This course is designed to empower healthcare leaders with the digital and genomic literacy required to deliver personalized, data-driven patient care in a modern clinical environment.

What You'll Learn

The molecular principles of drug-gene interactions and their impact on therapeutic index.

How to use AI-powered variant callers to identify clinically significant genetic markers.

Translation of PGx lab reports into precise medication dosing and selection strategies.

Methods for embedding Genomic Medicine alerts into digital hospital workflows.

Strategies for addressing Ethical, Legal, and Social Implications (ELSI) in genomic testing.

Cost-benefit modeling for implementing pre-emptive pharmacogenomic screening programs.

Curriculum

  • The molecular principles of drug-gene interactions and their impact on therapeutic index.
    Lesson
  • How to use AI-powered variant callers to identify clinically significant genetic markers.
    Lesson
  • Translation of PGx lab reports into precise medication dosing and selection strategies.
    Lesson
  • Methods for embedding Genomic Medicine alerts into digital hospital workflows.
    Lesson
  • Strategies for addressing Ethical, Legal, and Social Implications (ELSI) in genomic testing.
    Lesson
  • Cost-benefit modeling for implementing pre-emptive pharmacogenomic screening programs.
    Lesson
WhatsApp